Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 16 | 0 | 0 | 16 |
Chain B, HADH2 protein | 16 | 0 | 0 | 16 |
Chain A, 2-oxoglutarate Oxygenase | 14 | 0 | 0 | 14 |
Chain A, Cruzipain | 9 | 0 | 0 | 9 |
Chain A, Methyltransferase Wbdd | 0 | 1 | 0 | 1 |
thioredoxin reductase | 26 | 0 | 0 | 26 |
15-lipoxygenase, partial | 6 | 0 | 0 | 6 |
ATAD5 protein, partial | 12 | 0 | 0 | 12 |
NFKB1 protein, partial | 9 | 0 | 0 | 9 |
TDP1 protein | 26 | 0 | 0 | 26 |
Thrombopoietin | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 26 | 0 | 0 | 26 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 13 | 0 | 0 | 13 |
thyroid stimulating hormone receptor | 15 | 0 | 0 | 15 |
regulator of G-protein signaling 4 | 18 | 0 | 0 | 18 |
EWS/FLI fusion protein | 15 | 0 | 0 | 15 |
67.9K protein | 7 | 0 | 0 | 7 |
Parkin | 7 | 0 | 0 | 7 |
euchromatic histone-lysine N-methyltransferase 2 | 31 | 0 | 0 | 31 |
cytochrome P450 2D6 isoform 1 | 9 | 0 | 0 | 9 |
cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
cytochrome P450 2C19 precursor | 10 | 0 | 0 | 10 |
cytochrome P450 2C9 precursor | 7 | 0 | 0 | 7 |
chromobox protein homolog 1 | 23 | 0 | 0 | 23 |
flap endonuclease 1 | 12 | 0 | 0 | 12 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 10 | 0 | 0 | 10 |
cytochrome P450 3A4 isoform 1 | 15 | 0 | 0 | 15 |
M-phase phosphoprotein 8 | 8 | 0 | 0 | 8 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 0 | 1 | 0 | 2 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PLK4 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 15 | 3 | 1 | 19 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 6 | 1 | 0 | 7 |
Bromodomain-containing protein 4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 12 | 0 | 12 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Integrin beta-3 | 4 | 0 | 0 | 4 |
Cytochrome P450 1A2 | 0 | 8 | 1 | 9 |
Integrin alpha-IIb | 4 | 0 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-4 | 2 | 4 | 3 | 10 |
Serine/threonine-protein kinase pim-1 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 2 | 4 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit beta-1 | 15 | 3 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit delta | 15 | 3 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 15 | 3 | 2 | 20 |
Casein kinase II subunit alpha' | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 15 | 3 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 15 | 3 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 15 | 3 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 15 | 3 | 1 | 19 |
Proteinase-activated receptor 1 | 0 | 0 | 0 | 1 |
Bromodomain-containing protein 2 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 2C | 0 | 12 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 15 | 3 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 15 | 3 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 15 | 3 | 1 | 19 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 10 | 0 | 10 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 2 | 0 | 3 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0 | 1 | 0 | 3 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 10 | 0 | 0 | 11 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 2 | 0 | 3 |
Glycogen synthase kinase-3 beta | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
Serine/threonine-protein kinase PLK1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 15 | 3 | 2 | 20 |
Gamma-aminobutyric acid receptor subunit beta-3 | 15 | 3 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit beta-2 | 15 | 3 | 2 | 20 |
Casein kinase II subunit beta | 0 | 3 | 0 | 3 |
Casein kinase II subunit alpha | 0 | 3 | 0 | 3 |
DNA-dependent protein kinase catalytic subunit | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Bromodomain-containing protein 3 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase pim-3 | 0 | 1 | 0 | 1 |
Phosphoinositide 3-kinase regulatory subunit 5 | 0 | 1 | 0 | 1 |
GABA theta subunit | 15 | 3 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit epsilon | 15 | 3 | 1 | 19 |
Serine/threonine-protein kinase PLK3 | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase PLK2 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 16 | 0 | 0 | 16 |
Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
IDH1 | 8 | 0 | 0 | 8 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 3 |
Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 14 | 0 | 0 | 14 |
RAR-related orphan receptor gamma | 30 | 0 | 0 | 30 |
GLI family zinc finger 3 | 32 | 0 | 0 | 32 |
AR protein | 34 | 0 | 0 | 34 |
retinoic acid nuclear receptor alpha variant 1 | 26 | 0 | 0 | 26 |
retinoid X nuclear receptor alpha | 20 | 0 | 0 | 20 |
estrogen nuclear receptor alpha | 41 | 0 | 0 | 41 |
peroxisome proliferator-activated receptor delta | 14 | 0 | 0 | 14 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 21 | 0 | 0 | 21 |
activating transcription factor 6 | 10 | 0 | 0 | 10 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 13 | 0 | 0 | 13 |
Histone H2A.x | 13 | 0 | 0 | 13 |
thyroid hormone receptor beta isoform a | 11 | 0 | 0 | 11 |
heat shock protein beta-1 | 7 | 0 | 0 | 7 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 23 | 0 | 0 | 23 |
lamin isoform A-delta10 | 23 | 0 | 0 | 23 |
Voltage-dependent calcium channel gamma-2 subunit | 14 | 0 | 0 | 14 |
Glutamate receptor 2 | 14 | 0 | 0 | 14 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 18 | 0 | 0 | 18 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 13 | 0 | 0 | 13 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 5 | 0 | 0 | 5 |
Chain A, Protocatechuate 3,4-dioxygenase | 0 | 0 | 1 | 1 |
Chain M, Protocatechuate 3,4-dioxygenase | 0 | 0 | 1 | 1 |
Olfactory receptor class A-like protein 1 | 0 | 0 | 1 | 1 |
Luciferase | 14 | 0 | 0 | 14 |
endonuclease IV | 5 | 0 | 0 | 5 |
RGS12 | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 15 | 0 | 0 | 15 |
GLS protein | 11 | 0 | 0 | 11 |
Microtubule-associated protein tau | 13 | 0 | 0 | 13 |
alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
hypothetical protein, conserved | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 17 | 0 | 0 | 17 |
lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 isoform 1 | 5 | 0 | 0 | 5 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 10 | 0 | 0 | 10 |
intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase beta | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 12 | 0 | 0 | 12 |
geminin | 23 | 0 | 0 | 23 |
alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 2 | 2 |
muscarinic acetylcholine receptor M1 | 12 | 0 | 0 | 12 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 2 | 4 |
Zinc finger protein mex-5 | 0 | 0 | 2 | 2 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
GALC protein | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 3 | 26 | 0 | 0 | 26 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 16 | 0 | 0 | 16 |
glucocorticoid receptor [Homo sapiens] | 25 | 0 | 0 | 25 |
estrogen-related nuclear receptor alpha | 27 | 0 | 0 | 27 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
arylsulfatase A | 12 | 0 | 0 | 12 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
peripheral myelin protein 22 | 10 | 0 | 0 | 10 |
muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
ATP-binding cassette sub-family C member 3 | 0 | 28 | 0 | 28 |
Multidrug resistance-associated protein 4 | 0 | 28 | 0 | 28 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 12 | 0 | 5 | 1 | 11 |
Prolyl endopeptidase | 0 | 2 | 0 | 2 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 3 |
Bile salt export pump | 0 | 40 | 0 | 40 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 9 | 1 | 17 |
Carbonic anhydrase 2 | 0 | 9 | 2 | 17 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 5 | 1 | 10 |
Cathepsin B | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 11 | 1 | 13 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 3 | 0 | 3 |
Cytochrome P450 2D6 | 0 | 7 | 1 | 8 |
Cytochrome P450 2A6 | 0 | 5 | 2 | 7 |
Cytochrome P450 2C9 | 0 | 9 | 1 | 11 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
Androgen receptor | 0 | 8 | 0 | 8 |
Translocator protein | 0 | 2 | 0 | 2 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 2 | 0 | 2 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 6 | 1 | 11 |
Carbonic anhydrase 6 | 0 | 5 | 1 | 10 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 1 | 2 | 0 | 5 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 2 |
Endochitinase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 0 | 4 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Cytochrome P450 2C19 | 0 | 5 | 1 | 6 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
Carbonic anhydrase 5A, mitochondrial | 0 | 5 | 2 | 12 |
Carbonic anhydrase | 0 | 3 | 0 | 5 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 5 | 1 | 10 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
D(2) dopamine receptor | 0 | 6 | 2 | 8 |
Cholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 4 |
Squalene synthase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 4 | 2 | 7 |
Carbonic anhydrase 9 | 0 | 6 | 1 | 12 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase, alpha family | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 5 |
Carbonic anhydrase | 0 | 2 | 0 | 5 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 3 | 1 | 5 |
Canalicular multispecific organic anion transporter 1 | 0 | 27 | 0 | 27 |
Carbonic anhydrase 4 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 15 | 0 | 4 | 0 | 7 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 5 | 0 | 8 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 5 | 1 | 11 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 5 | 1 | 11 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 6 | 0 | 0 | 6 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 8 | 0 | 0 | 8 |
Chain A, Xcogt | 0 | 0 | 1 | 1 |
Chain A, Xcogt | 0 | 0 | 1 | 1 |
Chain A, Xcogt | 0 | 0 | 1 | 1 |
USP1 protein, partial | 11 | 0 | 0 | 11 |
vitamin D3 receptor isoform VDRA | 12 | 0 | 0 | 12 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 6 | 0 | 0 | 6 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
acetylcholinesterase | 11 | 0 | 0 | 11 |
estrogen receptor 2 (ER beta) | 12 | 0 | 0 | 12 |
progesterone receptor | 16 | 0 | 0 | 16 |
farnesoid X nuclear receptor | 12 | 0 | 0 | 12 |
cytochrome P450 2D6 | 13 | 0 | 0 | 13 |
peroxisome proliferator activated receptor gamma | 17 | 0 | 0 | 17 |
aryl hydrocarbon receptor | 18 | 0 | 0 | 18 |
thyroid stimulating hormone receptor | 11 | 0 | 0 | 11 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
potassium voltage-gated channel subfamily H member 2 isoform d | 9 | 0 | 0 | 9 |
thyroid hormone receptor beta isoform 2 | 17 | 0 | 0 | 17 |
mitogen-activated protein kinase 1 | 7 | 0 | 0 | 7 |
nuclear receptor ROR-gamma isoform 1 | 8 | 0 | 0 | 8 |
lethal factor (plasmid) | 10 | 0 | 0 | 10 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 5 |
Cellular tumor antigen p53 | 20 | 0 | 0 | 20 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 1 | 2 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 6 | 2 | 10 |
Alpha-1B adrenergic receptor | 0 | 7 | 0 | 7 |
D | 0 | 3 | 0 | 3 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 11 | 1 | 12 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 6 | 2 | 10 |
D(4) dopamine receptor | 0 | 3 | 1 | 5 |
D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 6 | 1 | 8 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
Spike glycoprotein | 13 | 0 | 1 | 14 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
D | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 7 | 0 | 0 | 7 |
Ataxin-2 | 9 | 0 | 0 | 9 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
pregnane X nuclear receptor | 25 | 0 | 0 | 25 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 12 | 2 | 17 |
Muscarinic acetylcholine receptor M4 | 0 | 10 | 1 | 13 |
Muscarinic acetylcholine receptor M1 | 0 | 11 | 1 | 15 |
Muscarinic acetylcholine receptor M3 | 0 | 10 | 1 | 14 |
Muscarinic acetylcholine receptor M4 | 0 | 11 | 1 | 15 |
Muscarinic acetylcholine receptor M5 | 0 | 10 | 1 | 14 |
Muscarinic acetylcholine receptor M5 | 0 | 10 | 1 | 13 |
Muscarinic acetylcholine receptor M2 | 0 | 11 | 2 | 17 |
Muscarinic acetylcholine receptor M1 | 0 | 11 | 4 | 19 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 9 | 1 | 12 |
Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 0 | 3 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 2 | 1 | 3 |
D(1A) dopamine receptor | 7 | 0 | 0 | 7 |
histone acetyltransferase KAT2A isoform 1 | 16 | 0 | 0 | 16 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 6 | 0 | 0 | 6 |
G | 13 | 0 | 0 | 13 |
Interferon beta | 18 | 0 | 0 | 18 |
HLA class I histocompatibility antigen, B alpha chain | 13 | 0 | 0 | 13 |
Inositol hexakisphosphate kinase 1 | 13 | 0 | 0 | 13 |
cytochrome P450 2C9, partial | 13 | 0 | 0 | 13 |
relaxin receptor 1 isoform 1 | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 8 | 0 | 0 | 8 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
Bile salt export pump | 0 | 6 | 0 | 6 |
Albumin | 0 | 6 | 4 | 10 |
Lanosterol 14-alpha demethylase | 0 | 3 | 0 | 3 |
PINK1 | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
Caspase-7 | 4 | 0 | 0 | 4 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 4 | 0 | 0 | 4 |
prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
caspase-3 | 4 | 0 | 0 | 4 |
serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 6 | 1 | 1 | 8 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
ORF73 | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 2 | 0 | 3 |
DNA gyrase subunit A | 0 | 3 | 0 | 7 |
DNA gyrase subunit B | 0 | 3 | 0 | 7 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 2 | 0 | 3 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 5 |
DNA gyrase subunit A | 0 | 2 | 0 | 3 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 3 | 0 | 5 |
DNA gyrase subunit A | 0 | 3 | 0 | 5 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 8 | 0 | 10 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 2 | 0 | 2 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
General amino-acid permease GAP1 | 0 | 0 | 0 | 1 |
Cytochrome P450 2A5 | 0 | 2 | 0 | 2 |
Fumarate hydratase | 5 | 0 | 0 | 5 |
PPM1D protein | 4 | 0 | 0 | 4 |
polyprotein | 5 | 0 | 0 | 5 |
huntingtin isoform 2 | 4 | 0 | 0 | 4 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
chaperonin GroEL | 1 | 0 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 7 | 1 | 8 |
Glycogen phosphorylase, brain form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-2C adrenergic receptor | 0 | 5 | 1 | 6 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 3 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Histone-lysine N-methyltransferase SETD7 | 0 | 2 | 0 | 2 |
Transporter | 0 | 2 | 1 | 4 |
nonstructural protein 1 | 6 | 0 | 0 | 6 |
glucocerebrosidase | 4 | 0 | 0 | 4 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 2 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Transthyretin | 0 | 0 | 1 | 3 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 2 | 1 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 3 |
UDP-glucuronosyltransferase 1-6 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A1 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
C-X-C chemokine receptor type 1 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 7 | 0 | 7 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 1 | 1 | 2 |
chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
SMAD family member 2 | 10 | 0 | 0 | 10 |
SMAD family member 3 | 10 | 0 | 0 | 10 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 15 | 0 | 0 | 15 |
thyrotropin-releasing hormone receptor | 4 | 0 | 0 | 4 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
large T antigen | 0 | 2 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 6 | 0 | 0 | 6 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 5 | 0 | 0 | 5 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Glucocorticoid receptor | 0 | 8 | 2 | 15 |
Glycine receptor subunit alpha-1 | 0 | 9 | 0 | 9 |
Glycine receptor subunit beta | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-2 | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-3 | 0 | 8 | 0 | 8 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 8 | 0 | 0 | 8 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
ATP-binding cassette sub-family C member 9 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 2 | 3 |
Chymotrypsinogen A | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 2 | 0 | 2 |
ATP synthase subunit beta, mitochondrial | 0 | 1 | 0 | 1 |
ATP synthase subunit delta, mitochondrial | 0 | 1 | 0 | 1 |
ATP synthase subunit gamma, mitochondrial | 0 | 1 | 0 | 1 |
ATP synthase subunit epsilon, mitochondrial | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 1 | 1 | 2 |
Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 1 | 0 | 1 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 8 | 0 | 1 | 0 | 1 |
ATP-sensitive inward rectifier potassium channel 11 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 1 | 3 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
calpain II, partial | 0 | 1 | 0 | 1 |
PAX8 | 0 | 0 | 0 | 2 |
SUMO-1 | 0 | 1 | 0 | 1 |
pregnane X receptor | 6 | 0 | 0 | 6 |
Mcl-1 | 0 | 1 | 0 | 1 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
TSHR protein | 1 | 0 | 0 | 1 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
Smad3 | 4 | 0 | 0 | 4 |
envelope glycoprotein | 0 | 1 | 0 | 1 |
heat shock protein 90 | 0 | 0 | 1 | 1 |
heat shock 70kDa protein 1A | 0 | 1 | 0 | 1 |
galactokinase | 2 | 0 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
tumor necrosis factor | 2 | 0 | 0 | 2 |
neuropeptide Y receptor type 1 | 0 | 0 | 1 | 1 |
neuropeptide Y receptor type 2 | 0 | 0 | 1 | 1 |
small ubiquitin-related modifier 2 isoform b precursor | 0 | 1 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 10 | 0 | 0 | 10 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
enteropeptidase precursor | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
fatty acid synthase | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
heat shock cognate 71 kDa protein isoform 1 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
Vpr | 2 | 0 | 0 | 2 |
4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase | 1 | 0 | 0 | 1 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
streptokinase A precursor | 0 | 0 | 2 | 2 |
exodeoxyribonuclease V subunit RecD | 0 | 2 | 0 | 2 |
exodeoxyribonuclease V subunit RecB | 0 | 2 | 0 | 2 |
exodeoxyribonuclease V subunit RecC | 0 | 2 | 0 | 2 |
heat shock cognate 71 kDa protein isoform 2 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Lck | 0 | 3 | 0 | 3 |
Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
Replicase polyprotein 1a | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 4 | 1 | 5 |
Adenosine receptor A3 | 0 | 5 | 0 | 5 |
Replicase polyprotein 1ab | 0 | 4 | 2 | 6 |
60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Endoplasmic reticulum chaperone BiP | 0 | 1 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 6 | 1 | 7 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Alpha-synuclein | 1 | 2 | 0 | 3 |
Caspase-7 | 2 | 0 | 0 | 2 |
10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Mitogen-activated protein kinase 14 | 0 | 3 | 0 | 3 |
Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 3 | 0 | 3 |
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | 0 | 1 | 0 | 1 |
phosphoglycerate kinase | 3 | 0 | 0 | 3 |
heat shock protein 90, putative | 0 | 0 | 0 | 2 |
M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
BZLF2 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 0 | 1 | 1 |
Lysosomal protective protein | 0 | 1 | 0 | 1 |
Fatty acid synthase | 0 | 1 | 0 | 1 |
Liver carboxylesterase | 0 | 1 | 0 | 1 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
Caspase-1 | 0 | 1 | 0 | 1 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
dopamine D1 receptor | 4 | 0 | 0 | 4 |
WRN | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
glucokinase regulatory protein | 2 | 0 | 0 | 2 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 4 | 0 | 8 |
Plasma kallikrein | 0 | 0 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
Tyrosinase | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 3 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 2 |
Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
SLC16A10 protein | 0 | 0 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 2 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 2 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
interleukin 8 | 3 | 0 | 0 | 3 |
ClpP | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
Cytochrome P450 1A1 | 0 | 3 | 1 | 4 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Aromatase | 0 | 2 | 0 | 2 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 3 | 1 | 4 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 2 | 5 |
Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 2 | 5 |
Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 4 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Acetylcholine-binding protein | 0 | 1 | 1 | 2 |
Acetylcholine receptor subunit epsilon | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Cytochrome P450 2A13 | 0 | 2 | 2 | 4 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Soluble acetylcholine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 2 | 2 | 5 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Integrin beta | 0 | 0 | 1 | 1 |
Glycoprotein IIb | 0 | 0 | 1 | 1 |
STE24 | 0 | 0 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
Trypsin | 0 | 0 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Chain A, PROTEIN (CATECHOL OXIDASE) | 0 | 1 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Succinyl-diaminopimelate desuccinylase | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 38 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor DM1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Glutamate 5-kinase | 0 | 0 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Amino acid transporter | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, APH(2')-Id | 0 | 1 | 0 | 1 |
glucose-6-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
Nrf2 | 1 | 0 | 0 | 1 |
signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
Neuraminidase | 0 | 2 | 0 | 2 |
hexokinase | 0 | 1 | 0 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Maltase-glucoamylase, intestinal | 0 | 1 | 0 | 1 |
NUAK family SNF1-like kinase 1 | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
Arginase | 0 | 1 | 0 | 1 |
Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 1 | 2 |
Prothrombin | 0 | 1 | 0 | 1 |
Cationic trypsin | 0 | 1 | 0 | 1 |
Chymotrypsin-like elastase family member 1 | 0 | 1 | 0 | 1 |
Protein E6 | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Interstitial collagenase | 0 | 1 | 1 | 2 |
Phospholipase A2 | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Epoxide hydrolase 1 | 0 | 1 | 0 | 1 |
Trypsin-1 | 0 | 1 | 0 | 1 |
Trypsin-2 | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Yes | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 0 | 1 |
Insulin-like growth factor 1 receptor | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 3 | 1 | 5 |
Neutrophil elastase | 0 | 2 | 0 | 2 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 1 | 2 |
Hepatocyte growth factor receptor | 0 | 1 | 0 | 1 |
Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
Alpha-amylase 1A | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Sialidase | 0 | 1 | 0 | 1 |
Malate dehydrogenase | 0 | 2 | 0 | 2 |
Solute carrier family 2, facilitated glucose transporter member 2 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase B-raf | 0 | 2 | 0 | 2 |
G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Chymotrypsinogen B | 0 | 2 | 0 | 2 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 2 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
Cytosol aminopeptidase | 0 | 1 | 0 | 1 |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase receptor UFO | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
RAC-alpha serine/threonine-protein kinase | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Trypsin-3 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
Macrophage metalloelastase | 0 | 1 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase SYK | 0 | 1 | 1 | 2 |
Collagenase 3 | 0 | 1 | 0 | 1 |
1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 4 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase Nek2 | 0 | 1 | 0 | 1 |
Oligo-1,6-glucosidase IMA1 | 0 | 1 | 0 | 1 |
Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 2 | 0 | 2 |
Anthrax toxin receptor 2 | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 2 | 0 | 2 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 4 |
Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
Heat shock factor protein 1 | 0 | 1 | 0 | 1 |
Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
Cyclin homolog | 0 | 1 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 2 | 0 | 2 |
Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
Focal adhesion kinase 1 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 1 | 0 | 1 |
ELAV-like protein 3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
ELAV-like protein 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase N1 | 0 | 1 | 0 | 1 |
Probable maltase-glucoamylase 2 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Casein kinase II subunit alpha 3 | 0 | 2 | 0 | 2 |
Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C21 | 0 | 2 | 0 | 2 |
Enoyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
3-oxoacyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 1 | 0 | 1 |
Aurora kinase B | 0 | 1 | 0 | 1 |
Chymotrypsin-C | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
Serine/threonine-protein kinase Nek6 | 0 | 1 | 0 | 1 |
NADPH oxidase 4 | 0 | 1 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
Short transient receptor potential channel 5 | 0 | 1 | 0 | 1 |
ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
Sialidase-2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain H, Immunoglobulin Igg1 Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Immunoglobulin Igg1 Lambda Light Chain | 0 | 0 | 1 | 1 |
Chain A, DODECIN | 0 | 0 | 1 | 1 |
Chain A, DODECIN | 0 | 0 | 1 | 1 |
Chain C, DODECIN | 0 | 0 | 1 | 1 |
Chain E, DODECIN | 0 | 0 | 1 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Riboflavin-binding protein | 0 | 1 | 1 | 2 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 0 | 1 |
Glycine receptor subunit beta | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 2 |
Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
cGMP-gated cation channel alpha-1 | 0 | 0 | 1 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Protein Rev | 0 | 0 | 1 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Chain A, Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 0 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 0 | 1 |
RAF proto-oncogene serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 2 | 0 | 1 | 0 | 1 |
MAP kinase-activated protein kinase 5 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |